One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization

World J Gastroenterol. 2014 May 7;20(17):5131-4. doi: 10.3748/wjg.v20.i17.5131.

Abstract

We report the case of a 57-year-old man who was diagnosed with a large unresectable cholangiocarcinoma associated with 2 satellite nodules and without clear margins with the right hepatic vein. Despite 4 cycles of GEMOX (stopped due to a hypertransaminasemia believed to be due to gemcitabine) and 4 cycles of FOLFIRINOX, the tumor remained stable and continued to be considered unresectable. Radioembolization (resin microspheres, SIRS-spheres) targeting the left liver (474 MBq) and segment IV (440 MBq) was performed. This injection was very well tolerated, and 4 more cycles of FOLFIRINOX were given while waiting for radioembolization efficacy. On computed tomography scan, a partial response was observed; the tumor was far less hypervascularized, and a margin was observed between the tumor and the right hepatic vein. A left hepatectomy enlarged to segment VIII was performed. On pathological exam, most of the tumor was acellular, with dense fibrosis around visible microspheres. Viable cells were observed only at a distance from beads. Radioembolization can be useful in the treatment of cholangiocarcinoma, allowing in some cases a secondary resection.

Keywords: Combined treatments; Intrahepatic cholangiocarcinomal; Radioembolization; Surgery.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bile Duct Neoplasms / diagnosis
  • Bile Duct Neoplasms / surgery
  • Bile Duct Neoplasms / therapy*
  • Bile Ducts, Intrahepatic / surgery
  • Biopsy
  • Chemotherapy, Adjuvant
  • Cholangiocarcinoma / diagnosis
  • Cholangiocarcinoma / surgery
  • Cholangiocarcinoma / therapy*
  • Embolization, Therapeutic / methods*
  • Hepatectomy*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neoadjuvant Therapy / methods*
  • Radiopharmaceuticals / therapeutic use*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Radiopharmaceuticals